Toric intraocular lens Vivinex™multiSert™

Clinically proven rotational stability. More than 96% of implanted lenses rotated ≤5° including eyes with high axial lengths Glistening-free hydrophobic acrylic IOL material Incorporates the Vivinex proprietary aspheric optic design which partially compensates for corneal spherical aberration and is more tolerant to sources of coma than standard aspheric designs Active oxygen processing treatment, a smooth surface, and square optic edge to reduce PCO Reliable outcomes through outstanding rotational stability The Vivinex™ IOL platform shows outstanding rotational stability between surgery and one week post op, without outliders, when compared with AcrySof®*, Tecnis®*, and enVista® Distribution of absolute rotation between end of surgery and 6 months postoperative. 100% of VivinexTM Toric IOLs had less than 10° of rotation between the end of surgery and 6 months postoperatively. Glistening-free clarity In vitro glistening formation at 14x magnification Proven glistening-free IOL material with Grade 0 based on Miyata et al. in laboratory testings. More than meets the eye Watch how Vivinex™ improves image quality and reduces coma compared with other traditional negative aspheric IOLs. Vivinex™ combines an active oxygen processing treatment, a square edge design and one of the smoothest and most regular IOL surfaces to provide a low incidence of PCO.